Novartis Investigative Site

Zhytomyr 10002

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease (COPD), Leukaemia, Lymphocytic, Chronic

Studies at this site

• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early
• A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation. — Completed